December 2009 — MDCO-216 acquisition

December 2009 — MDCO-216, a naturally occurring variant of a protein found in human high-density lipoprotein, is acquired from Pfizer.

Date: 
Tuesday, December 1, 2009
Category: 
Acute Cardiovascular